According to Santos-Gallego et al., Empagliflozin therapy enhanced heart function and mitochondria energetics in porcine model of HF, which was achieved by upregulating the expression of AMPK and PGC-1α (15). The gene discussed is PRKAA2; the disease is hydrops fetalis.